Community Health Systems, Inc. (CYH) Key Metrics
CYH valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $406.1M
- Enterprise value
- $10.48B
- P/E (TTM)
- 1.6 10-yr median 4.6
- Forward P/E
- 17.6
- PEG ratio
- 2.38
- Price / sales
- 0.0 10-yr median 0.0
- Price / book
- 0.5
- EV / EBITDA
- 6.0 10-yr median 9.2
- Dividend yield
- —
- Beta
- 1.89
CYH key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsCYH valuation Price multiples at each fiscal year-end price.
CYH returns How much profit the business earns on the capital it uses.
CYH per-share figures Results divided by the shares outstanding at year-end.
CYH financial health Debt, liquidity and how easily interest is covered.
CYH efficiency & capital use Working capital cycle and where the cash goes.
CYH valuation history
CYH returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
CYH debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
CYH cash returned to shareholders
CYH price vs earnings per share
CYH key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $421.2M | $395.0M | $408.3M | $561.9M | $1.74B | $865.9M | $329.8M | $317.9M | $476.1M | $619.0M |
| Enterprise value | $11.74B | $12.46B | $12.54B | $12.83B | $14.05B | $12.07B | $14.14B | $13.72B | $13.83B | $15.62B |
| P/E ratio | 0.8 | — | — | 12.2 | 7.6 | 1.7 | — | — | — | — |
| Price / sales | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| Price / book | — | — | — | — | — | — | — | — | — | 0.4 |
| Price / free cash flow | 2.0 | 3.3 | — | — | — | 0.5 | — | — | 2.3 | 0.4 |
| Price / operating cash flow | 0.8 | 0.8 | 1.9 | 1.9 | — | 0.4 | 0.9 | 1.2 | 0.6 | 0.5 |
| EV / sales | 0.9 | 1.0 | 1.0 | 1.1 | 1.1 | 1.0 | 1.1 | 1.0 | 0.9 | 0.8 |
| EV / EBITDA | 5.8 | 9.4 | 9.1 | 10.2 | 7.7 | 10.7 | 9.4 | 8.6 | 12.8 | 7.2 |
| EV / free cash flow | 56.4 | 103.8 | — | — | — | 6.9 | — | — | 68.1 | 10.5 |
| Earnings yield | 120.8% | −130.6% | −32.6% | 8.2% | 13.2% | 59.0% | −178.9% | −247.9% | −516.4% | −278.0% |
| Free cash flow yield | 49.4% | 30.4% | −62.9% | −20.5% | −34.5% | 200.7% | −16.1% | −79.6% | 42.6% | 240.6% |
| Dividend yield | — | — | — | 22.2% | 7.0% | 13.4% | 30.0% | 30.2% | 21.0% | 14.9% |
| Shareholder yield (dividends + buybacks) | 0.5% | 0.3% | 1.0% | 23.7% | 7.2% | 13.5% | 30.3% | 30.5% | 22.1% | 15.8% |
| Share price at fiscal year-end | $3.12 | $2.99 | $3.13 | $4.32 | $13.31 | $7.43 | $2.90 | $2.82 | $4.26 | $5.59 |
| Per share | ||||||||||
| Revenue per share | $92.48 | $95.64 | $95.75 | $93.89 | $94.70 | $101.15 | $116.14 | $125.57 | $137.36 | $166.51 |
| Earnings per share | $3.77 | −$3.91 | −$1.02 | $0.35 | $1.76 | $4.38 | −$5.19 | −$6.99 | −$22.00 | −$15.54 |
| Operating cash flow per share | $4.02 | $3.63 | $1.61 | $2.31 | −$1.00 | $18.69 | $3.38 | $2.43 | $6.92 | $10.27 |
| Free cash flow per share | $1.54 | $0.91 | −$1.97 | −$0.88 | −$4.59 | $14.91 | −$0.47 | −$2.24 | $1.82 | $13.45 |
| Cash per share | $1.93 | $0.28 | $0.29 | $0.91 | $3.88 | $14.38 | $1.90 | $1.74 | $5.04 | $2.15 |
| Book value per share | −$10.33 | −$14.49 | −$10.67 | −$10.51 | −$10.51 | −$13.94 | −$19.50 | −$13.62 | −$6.86 | $14.58 |
| Tangible book value per share | −$35.96 | −$44.47 | −$42.58 | −$44.26 | −$44.88 | −$52.76 | −$60.94 | −$57.81 | −$53.64 | −$50.39 |
| Dividends per share | — | — | — | $0.96 | $0.93 | $1.00 | $0.87 | $0.85 | $0.89 | $0.83 |
| Capex per share | $2.48 | $2.73 | $3.58 | $3.19 | $3.59 | $3.78 | $3.85 | $4.67 | $5.10 | $7.83 |
| Debt per share | $85.78 | $91.61 | $93.33 | $95.25 | $98.18 | $110.53 | $123.33 | $120.61 | $124.48 | $137.67 |
| Shares outstanding | 135.0M | 132.1M | 130.4M | 130.1M | 130.6M | 116.5M | 113.7M | 112.7M | 111.8M | 110.7M |
| Change in shares outstanding | +2.2% | +1.3% | +0.3% | −0.4% | +12.1% | +2.5% | +0.9% | +0.9% | +0.9% | −3.7% |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | — | — | — | — | — | — | — | — | — | −61.1% |
| Return on invested capital (ROIC) | −92.2% | 4.1% | 4.4% | 3.9% | 10.1% | 10.6% | 4.4% | 1.3% | −10.2% | −3.6% |
| Return on assets (ROA) | 3.7% | −3.6% | −0.9% | 0.3% | 1.5% | 3.2% | −3.7% | −4.7% | −12.5% | −7.1% |
| Return on tangible assets | 5.2% | −5.1% | −1.3% | 0.4% | 2.1% | 4.5% | −5.4% | −7.2% | −20.1% | −11.7% |
| Free cash flow margin | 1.7% | 0.9% | −2.1% | −0.9% | −4.9% | 14.7% | −0.4% | −1.8% | 1.3% | 8.1% |
| Income quality (OCF / net income) | 1.07 | — | — | 6.52 | −0.57 | 4.26 | — | — | — | — |
| Financial health | ||||||||||
| Total debt | $11.58B | $12.10B | $12.17B | $12.39B | $12.82B | $12.88B | $14.03B | $13.60B | $13.91B | $15.24B |
| Cash & short-term investments | $260.0M | $37.0M | $38.0M | $118.0M | $507.0M | $1.68B | $216.0M | $196.0M | $563.0M | $238.0M |
| Net debt | $11.32B | $12.06B | $12.14B | $12.27B | $12.31B | $11.21B | $13.81B | $13.40B | $13.35B | $15.01B |
| Debt / equity | — | — | — | — | — | — | — | — | — | 9.44 |
| Debt / assets | 0.88 | 0.86 | 0.84 | 0.84 | 0.84 | 0.80 | 0.90 | 0.86 | 0.80 | 0.69 |
| Net debt / EBITDA | 5.60 | 9.08 | 8.83 | 9.79 | 6.77 | 9.91 | 9.15 | 8.42 | 12.40 | 6.88 |
| Current ratio | 1.46 | 1.41 | 1.50 | 1.41 | 1.47 | 1.60 | 1.50 | 1.48 | 1.73 | 1.62 |
| Quick ratio | 1.32 | 1.27 | 1.34 | 1.25 | 1.32 | 1.48 | 1.35 | 1.32 | 1.54 | 1.45 |
| Interest coverage | -11.4 | 0.6 | 1.2 | 1.0 | 1.6 | 1.1 | 0.6 | 0.2 | -2.0 | -0.9 |
| Working capital | $1.03B | $956.0M | $1.07B | $896.0M | $1.11B | $1.70B | $1.15B | $1.16B | $1.71B | $1.78B |
| Invested capital | $9.93B | $10.15B | $10.74B | $10.90B | $10.94B | $9.58B | $11.59B | $11.87B | $12.58B | $16.62B |
| Tangible asset value | −$4.30B | −$5.28B | −$4.99B | −$5.12B | −$5.30B | −$5.58B | −$6.35B | −$5.94B | −$5.39B | −$4.91B |
| Net current asset value | −$10.81B | −$12.07B | −$12.07B | −$12.32B | −$12.55B | −$12.55B | −$13.82B | −$13.27B | −$13.55B | −$15.00B |
| Graham net-net per share | −$88.34 | −$100.93 | −$102.01 | −$103.84 | −$104.98 | −$117.29 | −$132.40 | −$128.99 | −$133.55 | −$150.48 |
| Capital allocation | ||||||||||
| Dividends paid | — | — | — | $125.0M | $121.0M | $116.0M | $99.0M | $96.0M | $100.0M | $92.0M |
| Share buybacks (net) | $2.0M | $1.0M | $4.0M | $8.0M | $5.0M | $1.0M | $1.0M | $1.0M | $5.0M | $6.0M |
| Dividend payout ratio | — | — | — | 271.7% | 52.6% | 22.7% | — | — | — | — |
| Dividends + buybacks / free cash flow | 1.0% | 0.8% | — | — | — | 6.7% | — | — | 51.7% | 6.6% |
| Capex / revenue | 2.7% | 2.8% | 3.7% | 3.4% | 3.8% | 3.7% | 3.3% | 3.7% | 3.7% | 4.7% |
| Capex / operating cash flow | 61.7% | 75.0% | 222.4% | 138.3% | — | 20.2% | 113.8% | 192.3% | 73.7% | 76.3% |
| Capex / depreciation | 0.79 | 0.74 | 0.92 | 0.78 | 0.87 | 0.79 | 0.72 | 0.75 | 0.66 | 0.79 |
| Stock-based compensation / revenue | 0.1% | 0.1% | 0.2% | 0.2% | 0.2% | 0.1% | 0.1% | 0.1% | 0.2% | 0.2% |
| R&D / revenue | — | — | 0.6% | 0.7% | 0.9% | — | — | — | — | — |
| SG&A / revenue | 45.6% | 45.3% | 2.6% | 2.6% | 2.5% | 2.8% | 2.4% | 2.4% | 2.6% | 2.4% |
| Efficiency | ||||||||||
| Days sales outstanding | 68.8 | 69.5 | 65.7 | 64.5 | 62.5 | 69.0 | 67.7 | 65.0 | 70.1 | 71.1 |
| Days of inventory on hand | 10.5 | 16.3 | 16.8 | 17.7 | 17.3 | 17.1 | 17.0 | 17.7 | 16.8 | 16.6 |
| Days payables outstanding | 26.0 | 39.5 | 36.9 | 35.3 | 35.3 | 34.7 | 33.6 | 32.8 | 30.5 | 30.8 |
| Cash conversion cycle (days) | 53.2 | 46.3 | 45.6 | 46.9 | 44.6 | 51.4 | 51.2 | 49.8 | 56.4 | 56.9 |
| Receivables turnover | 5.31 | 5.26 | 5.55 | 5.66 | 5.84 | 5.29 | 5.39 | 5.61 | 5.21 | 5.13 |
| Payables turnover | 14.03 | 9.23 | 9.90 | 10.35 | 10.35 | 10.53 | 10.87 | 11.11 | 11.95 | 11.84 |
| Inventory turnover | 34.92 | 22.35 | 21.76 | 20.64 | 21.11 | 21.40 | 21.42 | 20.66 | 21.75 | 21.95 |
| Asset turnover | 0.92 | 0.89 | 0.86 | 0.82 | 0.79 | 0.75 | 0.84 | 0.85 | 0.78 | 0.76 |
| Average receivables | $2.35B | $2.40B | $2.25B | $2.16B | $2.12B | $2.23B | $2.45B | $2.52B | $2.95B | $3.59B |
| Average payables | $813.0M | $797.5M | $748.5M | $705.5M | $704.0M | $700.5M | $745.0M | $786.5M | $840.5M | $982.5M |
| Average inventory | $326.5M | $329.5M | $340.5M | $354.0M | $345.0M | $344.5M | $378.0M | $423.0M | $462.0M | $530.0M |
| Intangibles / total assets | 26.2% | 28.2% | 28.8% | 29.9% | 29.5% | 28.3% | 30.2% | 31.4% | 30.0% | 32.8% |
Computed from CYH's annual financial statements (latest annual report filed February 19, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
CYH valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), Community Health Systems traded at 0.8 times earnings, against a 10-year median of 4.6. Based on the latest twelve months, the trailing P/E is 1.6 and the forward P/E is 17.6. Community Health Systems earned a return on invested capital of −92.2% in fiscal 2025. It ended the year with $11.6 billion of debt and $260.0 million in cash and short-term investments, net debt of $11.3 billion. It returned $2.0 million to shareholders: $0 in dividends and $2.0 million in share buybacks, 1% of free cash flow. The share count rose 21.9% from 110.7M to 135.0M over 9 years.
See the CYH income statement, the CYH chart for price history, or the CYH stock overview for the latest quote and news.
CYH key metrics FAQ
What is Community Health Systems's P/E ratio?
Community Health Systems's trailing P/E ratio is 1.6 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 17.6. At the end of fiscal 2025 it was 0.8, compared with a 10-year median of 4.6.
What is Community Health Systems's EV/EBITDA?
Community Health Systems's enterprise value was 5.8 times EBITDA at the end of fiscal 2025 (enterprise value $11.7 billion, EBITDA $2.0 billion); the current EV/EBITDA is 6.0.
What is Community Health Systems's ROIC?
Community Health Systems's return on invested capital was −92.2% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does Community Health Systems have?
Community Health Systems had total debt of $11.6 billion at the end of fiscal 2025 and $11.3 billion of net debt (5.60 times EBITDA).
Does Community Health Systems buy back its shares?
Yes. Community Health Systems spent $2.0 million on net share repurchases in fiscal 2025 Shares outstanding changed +2.2% over the year, to 135.0M..
What is Community Health Systems's free cash flow yield?
Community Health Systems generated $208.0 million of free cash flow in fiscal 2025, a free cash flow yield of 49.4% on its market value at year-end ($421.2 million).
What is Community Health Systems's current ratio?
Community Health Systems's current ratio was 1.46 at the end of fiscal 2025: current assets were 1.46 times current liabilities.